{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:56:32Z","timestamp":1781614592794,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Multiple acyl-CoA dehydrogenase deficiency (MADD) is a rare autosomal recessive disorder. Riboflavin-responsive MADD (RR-MADD) represents a treatable subtype, though its molecular mechanisms are incompletely characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      Two patients presented to department of Rheumatology, the 3rd Affiliated Hospital of Sun Yet-sen University with progressive proximal muscle weakness. A 2-fluorine-18-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography (\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT) scan revealed marked metabolic hyperactivity in cervical and paraspinal muscles. Histopathology confirmed lipid storage myopathy, and exome sequencing (ES) identified electron transfer flavoprotein dehydrogenase gene (\n                      <jats:italic>ETFDH<\/jats:italic>\n                      ) mutations. Both patients harbored the common variant NM_004453.4:c.250G\u2009&gt;\u2009A (p.Ala84Thr). Case 1 exhibited homozygosity for this variant and potential XYY syndrome, while Case 2 carried a compound heterozygous mutation including a novel frameshift variant, NM_004453.4: c.265_266del (p. Gln89Valfs*6), and concurrent SLC25A13 mutation linked to adult-onset citrullinemia type II. Riboflavin supplementation achieved complete biochemical remission in both cases. Retrospective analysis for previous reports of homozygous single-locus missense\n                      <jats:italic>ETFDH<\/jats:italic>\n                      gene mutations revealed that patients with mutations in the flavin adenine dinucleotide binding domain (FAD) or the iron-sulfur cluster domain (Fe-S) exhibited a better response to riboflavin and better prognosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET\/CT is a promising tool for evaluating myopathic involvement in MADD. ES enables rapid and comprehensive diagnosis of MADD and detection of coexisting genetic disorders. The prognosis is related to mutation forms, mutation pathogenicity, and the located structural domain.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12920-025-02210-8","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:30:45Z","timestamp":1761046245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PET\/CT and exome sequencing in late onset multiple acyl-CoA dehydrogenase deficiency: a case series and literature review"],"prefix":"10.1186","volume":"18","author":[{"given":"Dong-Fang","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Tao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"12","key":"2210_CR1","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1016\/j.bbabio.2010.10.007","volume":"1797","author":"NJ Watmough","year":"2010","unstructured":"Watmough NJ, Frerman FE. The electron transfer flavoprotein: ubiquinone oxidoreductases. Biochim Biophys Acta. 2010;1797(12):1910\u20136. https:\/\/doi.org\/10.1016\/j.bbabio.2010.10.007.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"2210_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1080\/10409238.2021.1908952","volume":"56","author":"S Missaglia","year":"2021","unstructured":"Missaglia S, Tavian D, Angelini C. ETF dehydrogenase advances in molecular genetics and impact on treatment. Crit Rev Biochem Mol Biol. 2021;56(4):360\u201372. https:\/\/doi.org\/10.1080\/10409238.2021.1908952.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"2","key":"2210_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s00246-007-9119-6","volume":"29","author":"M Singla","year":"2008","unstructured":"Singla M, Guzman G, Griffin AJ, Bharati S. Cardiomyopathy in multiple acyl-CoA dehydrogenase deficiency: a clinico-pathological correlation and review of literature. Pediatr Cardiol. 2008;29(2):446\u201351. https:\/\/doi.org\/10.1007\/s00246-007-9119-6.","journal-title":"Pediatr Cardiol"},{"issue":"Pt 8","key":"2210_CR4","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/brain\/awm135","volume":"130","author":"RKJ Olsen","year":"2007","unstructured":"Olsen RKJ, Olpin SE, Andresen BS, Miedzybrodzka ZH, Pourfarzam M, Merinero B, et al. ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Brain. 2007;130(Pt 8):2045\u201354. https:\/\/doi.org\/10.1093\/brain\/awm135.","journal-title":"Brain"},{"key":"2210_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/8904_2017_27","volume":"38","author":"C Angelini","year":"2018","unstructured":"Angelini C, Tavian D, Missaglia S. Heterogeneous phenotypes in lipid storage myopathy due to ETFDH gene mutations. JIMD Rep. 2018;38:33\u201340. https:\/\/doi.org\/10.1007\/8904_2017_27.","journal-title":"JIMD Rep"},{"key":"2210_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-014-0117-5","volume":"9","author":"SC Gr\u00fcnert","year":"2014","unstructured":"Gr\u00fcnert SC. Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency. Orphanet J Rare Dis. 2014;9:117. https:\/\/doi.org\/10.1186\/s13023-014-0117-5.","journal-title":"Orphanet J Rare Dis"},{"key":"2210_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2022.100940","volume":"33","author":"K Yamada","year":"2022","unstructured":"Yamada K, Osawa Y, Kobayashi H, Bo R, Mushimoto Y, Hasegawa Y, et al. Clinical and molecular investigation of 37 Japanese patients with multiple acyl-CoA dehydrogenase deficiency: p.Y507D in ETFDH, a common Japanese variant, causes a mortal phenotype. Mol Genet Metab Rep. 2022;33:100940. https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100940.","journal-title":"Mol Genet Metab Rep"},{"issue":"1","key":"2210_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/humu.10226","volume":"22","author":"RKJ Olsen","year":"2003","unstructured":"Olsen RKJ, Andresen BS, Christensen E, Bross P, Skovby F, Gregersen N. Clear relationship between ETF\/ETFDH genotype and phenotype in patients with multiple acyl-CoA dehydrogenation deficiency. Hum Mutat. 2003;22(1):12\u201323. https:\/\/doi.org\/10.1002\/humu.10226.","journal-title":"Hum Mutat"},{"issue":"2","key":"2210_CR9","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1136\/jnnp.2009.176404","volume":"81","author":"B Wen","year":"2010","unstructured":"Wen B, Dai T, Li W, Zhao Y, Liu S, Zhang C, et al. Riboflavin-responsive lipid-storage myopathy caused by ETFDH gene mutations. J Neurol Neurosurg Psychiatry. 2010;81(2):231\u20136. https:\/\/doi.org\/10.1136\/jnnp.2009.176404.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"2210_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1399-0004.2010.01421.x","volume":"78","author":"M Lan","year":"2010","unstructured":"Lan M, Fu M, Liu Y, Huang C, Chang Y, Liu J, et al. High frequency of ETFDH c.250G >a mutation in Taiwanese patients with late-onset lipid storage myopathy. Clin Genet. 2010;78(6):565\u20139. https:\/\/doi.org\/10.1111\/j.1399-0004.2010.01421.x.","journal-title":"Clin Genet"},{"issue":"3","key":"2210_CR11","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10545-013-9671-6","volume":"37","author":"J Xi","year":"2014","unstructured":"Xi J, Wen B, Lin J, Zhu W, Luo S, Zhao C, et al. Clinical features and ETFDH mutation spectrum in a cohort of 90 Chinese patients with late-onset multiple acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 2014;37(3):399\u2013404. https:\/\/doi.org\/10.1007\/s10545-013-9671-6.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"2210_CR12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00109-011-0725-7","volume":"89","author":"ZQ Wang","year":"2011","unstructured":"Wang ZQ, Chen XJ, Murong SX, Wang N, Wu ZY. Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in Southern China confirmed the most common ETFDH mutation and high carrier frequency of c.250G\u2009>\u2009A. J Mol Med (Berl). 2011;89(6):569\u201376. https:\/\/doi.org\/10.1007\/s00109-011-0725-7.","journal-title":"J Mol Med (Berl)"},{"issue":"1","key":"2210_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-018-1221-2","volume":"18","author":"D Hong","year":"2018","unstructured":"Hong D, Yu Y, Wang Y, Xu Y, Zhang J. Acute-onset multiple acyl-CoA dehydrogenase deficiency mimicking Guillain-Barr\u00e9 syndrome: two cases report. BMC Neurol. 2018;18(1):219. https:\/\/doi.org\/10.1186\/s12883-018-1221-2.","journal-title":"BMC Neurol"},{"issue":"8","key":"2210_CR14","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1177\/0883073809351984","volume":"25","author":"LM Pollard","year":"2010","unstructured":"Pollard LM, Williams NR, Espinoza L, Wood TC, Spector EB, Schroer RJ, et al. Diagnosis, treatment, and long-term outcomes of late-onset (type III) multiple acyl-CoA dehydrogenase deficiency. J Child Neurol. 2010;25(8):954\u201360. https:\/\/doi.org\/10.1177\/0883073809351984.","journal-title":"J Child Neurol"},{"issue":"3","key":"2210_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.neurol.2015.11.008","volume":"172","author":"A B\u00e9hin","year":"2016","unstructured":"B\u00e9hin A, Acquaviva-Bourdain C, Souvannanorath S, Streichenberger N, Attarian S, Bassez G, et al. Multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of late-onset treatable metabolic disease. Rev Neurol (Paris). 2016;172(3):231\u201341. https:\/\/doi.org\/10.1016\/j.neurol.2015.11.008.","journal-title":"Rev Neurol (Paris)"},{"issue":"3","key":"2210_CR16","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.nmd.2009.01.008","volume":"19","author":"W-C Liang","year":"2009","unstructured":"Liang W-C, Ohkuma A, Hayashi YK, L\u00f3pez LC, Hirano M, Nonaka I, et al. ETFDH mutations, CoQ10 levels, and respiratory chain activities in patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency. Neuromuscul Disord. 2009;19(3):212\u20136. https:\/\/doi.org\/10.1016\/j.nmd.2009.01.008.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"2210_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14906","volume":"27","author":"M Li","year":"2024","unstructured":"Li M, Lin Z, Chen Y, Lin P, Xie Y, Wei J. A case report on multiple acyl-CoA dehydrogenase deficiency with severe myopathy and osteoporosis. Int J Rheum Dis. 2024;27(1): e14906. https:\/\/doi.org\/10.1111\/1756-185X.14906.","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"2210_CR18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.nmd.2021.01.006","volume":"31","author":"YC Kuo","year":"2021","unstructured":"Kuo YC, Hsueh HW, Hsueh SJ, Lee NC, Hsieh MJ, Chao CC, et al. A systematic review of late-onset and very-late-onset multiple acyl-coenzyme A dehydrogenase deficiency: cohort analysis and patient report from Taiwan. Neuromuscul Disord. 2021;31(3):218\u201325. https:\/\/doi.org\/10.1016\/j.nmd.2021.01.006.","journal-title":"Neuromuscul Disord"},{"issue":"13","key":"2210_CR19","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1097\/CM9.0000000000000288","volume":"132","author":"HZ Chen","year":"2019","unstructured":"Chen HZ, Jin M, Cai NQ, Lin XD, Liu XY, Xu LQ, et al. Rhabdomyolysis and respiratory insufficiency due to the common ETFDH mutation of c.250G >A in two patients with late-onset multiple acyl-CoA dehydrogenase deficiency. Chin Med J. 2019;132(13):1615\u20138. https:\/\/doi.org\/10.1097\/CM9.0000000000000288.","journal-title":"Chin Med J"},{"key":"2210_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.815523","volume":"13","author":"A Lupica","year":"2022","unstructured":"Lupica A, Oteri R, Volta S, Ghezzi D, Drago SFA, Rodolico C, et al. Diagnostic challenges in late onset multiple acyl-CoA dehydrogenase deficiency: clinical, morphological, and genetic aspects. Front Neurol. 2022;13:815523. https:\/\/doi.org\/10.3389\/fneur.2022.815523.","journal-title":"Front Neurol"},{"issue":"5","key":"2210_CR21","doi-asserted-by":"publisher","first-page":"983","DOI":"10.4103\/aian.aian_370_22","volume":"25","author":"S Korula","year":"2022","unstructured":"Korula S, Yoganathan S, Peter J, Chandran M, Christudass C, Danda S. Late onset multiple acyl-CoA dehydrogenase deficiency: a rare treatable neurometabolic disorder. Ann Indian Acad Neurol. 2022;25(5):983\u20135. https:\/\/doi.org\/10.4103\/aian.aian_370_22.","journal-title":"Ann Indian Acad Neurol"},{"issue":"03","key":"2210_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4103\/ijmbs.ijmbs_125_20","volume":"13","author":"A Arida","year":"2021","unstructured":"Arida A, Hamed W, Khaddam O, Alawadhi H, Hertecant J. Delayed presentation of late-onset glutamic aciduria type II: a disease of infancy presenting in an adult. Ibnosina J Med Biomed Sci. 2021;13(03):148\u201352. https:\/\/doi.org\/10.4103\/ijmbs.ijmbs_125_20.","journal-title":"Ibnosina J Med Biomed Sci"},{"key":"2210_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102689","volume":"48","author":"L Lian","year":"2021","unstructured":"Lian L, Chen D, Li J, Tan S, Que J, Feng H, et al. Late-onset MADD in Yemen caused by a novel ETFDH mutation misdiagnosed as ADEM. Mult Scler Relat Disord. 2021;48:102689. https:\/\/doi.org\/10.1016\/j.msard.2020.102689.","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"2210_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.36185\/2532-1900-003","volume":"39","author":"P Soldath","year":"2020","unstructured":"Soldath P, Lund AM, Vissing J. Late-onset MADD: a rare cause of cirrhosis and acute liver failure? Acta Myol. 2020;39(1):19\u201323. https:\/\/doi.org\/10.36185\/2532-1900-003.","journal-title":"Acta Myol"},{"issue":"3","key":"2210_CR25","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ymgme.2010.11.159","volume":"102","author":"Y Mushimoto","year":"2011","unstructured":"Mushimoto Y, Fukuda S, Hasegawa Y, Kobayashi H, Purevsuren J, Li H, et al. Clinical and molecular investigation of 19 Japanese cases of glutaric acidemia type 1. Mol Genet Metab. 2011;102(3):343\u20138. https:\/\/doi.org\/10.1016\/j.ymgme.2010.11.159.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"2210_CR26","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s12291-021-01007-7","volume":"38","author":"S Keshri","year":"2023","unstructured":"Keshri S, Goel AK, Johns J, Shah S. Liver failure in an infant of late-onset glutaric aciduria type II: case report. Indian J Clin Biochem. 2023;38(4):545\u20139. https:\/\/doi.org\/10.1007\/s12291-021-01007-7.","journal-title":"Indian J Clin Biochem"},{"issue":"5","key":"2210_CR27","doi-asserted-by":"publisher","first-page":"4396","DOI":"10.3892\/mmr.2020.11524","volume":"22","author":"C Wang","year":"2020","unstructured":"Wang C, Lv H, Xu X, Ma Y, Li Q. Clinical characteristics and gene mutation analysis of an adult patient with ETFDH\u2013related multiple acyl\u2013CoA dehydrogenase deficiency. Mol Med Rep. 2020;22(5):4396\u2013402. https:\/\/doi.org\/10.3892\/mmr.2020.11524.","journal-title":"Mol Med Rep"},{"issue":"3","key":"2210_CR28","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/mus.23979","volume":"49","author":"A Rosenbohm","year":"2014","unstructured":"Rosenbohm A, S\u00fcssmuth SD, Kassubek J, M\u00fcller H, Pontes C, Abicht A, et al. Novel ETFDH mutation and imaging findings in an adult with glutaric aciduria type II. Muscle Nerve. 2014;49(3):446\u201350. https:\/\/doi.org\/10.1002\/mus.23979.","journal-title":"Muscle Nerve"},{"key":"2210_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.672004","volume":"9","author":"MA Siano","year":"2021","unstructured":"Siano MA, Mandato C, Nazzaro L, Iannicelli G, Ciccarelli GP, Barretta F, et al. Hepatic presentation of late-onset multiple acyl-CoA dehydrogenase deficiency (MADD): case report and systematic review. Front Pediatr. 2021;9:672004. https:\/\/doi.org\/10.3389\/fped.2021.672004.","journal-title":"Front Pediatr"},{"issue":"3","key":"2210_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.braindev.2015.08.011","volume":"38","author":"K Yamada","year":"2016","unstructured":"Yamada K, Kobayashi H, Bo R, Takahashi T, Purevsuren J, Hasegawa Y, et al. Clinical, biochemical and molecular investigation of adult-onset glutaric acidemia type II: characteristics in comparison with pediatric cases. Brain Dev. 2016;38(3):293\u2013301. https:\/\/doi.org\/10.1016\/j.braindev.2015.08.011.","journal-title":"Brain Dev"},{"key":"2210_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.gene.2018.09.028","volume":"680","author":"MS Hassan","year":"2019","unstructured":"Hassan MS, Shaalan AA, Dessouky MI, Abdelnaiem AE, ElHefnawi M. A review study: computational techniques for expecting the impact of non-synonymous single nucleotide variants in human diseases. Gene. 2019;680:20\u201333. https:\/\/doi.org\/10.1016\/j.gene.2018.09.028.","journal-title":"Gene"},{"issue":"15","key":"2210_CR32","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1093\/hmg\/dds175","volume":"21","author":"N Cornelius","year":"2012","unstructured":"Cornelius N, Frerman FE, Corydon TJ, Palmfeldt J, Bross P, Gregersen N, et al. Molecular mechanisms of riboflavin responsiveness in patients with ETF-QO variations and multiple acyl-CoA dehydrogenation deficiency. Hum Mol Genet. 2012;21(15):3435\u201348. https:\/\/doi.org\/10.1093\/hmg\/dds175.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"2210_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbapap.2020.140393","volume":"1868","author":"TG Lucas","year":"2020","unstructured":"Lucas TG, Henriques BJ, Gomes CM. Conformational analysis of the riboflavin-responsive ETF:QO-p. Pro456Leu variant associated with mild multiple acyl-CoA dehydrogenase deficiency. Biochimica et Biophysica Acta (BBA). 2020;1868(6):140393. https:\/\/doi.org\/10.1016\/j.bbapap.2020.140393.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"3","key":"2210_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10545-013-9666-3","volume":"37","author":"EF Diekman","year":"2014","unstructured":"Diekman EF, van der Pol WL, Nievelstein RAJ, Houten SM, Wijburg FA, Visser G. Muscle MRI in patients with long-chain fatty acid oxidation disorders. J Inherit Metab Dis. 2014;37(3):405\u201313. https:\/\/doi.org\/10.1007\/s10545-013-9666-3.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"2210_CR35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/nbm.1549","volume":"24","author":"H M\u00fcller","year":"2011","unstructured":"M\u00fcller H, Raudies F, Unrath A, Neumann H, Ludolph AC, Kassubek J. Quantification of human body fat tissue percentage by MRI. NMR Biomed. 2011;24(1):17\u201324. https:\/\/doi.org\/10.1002\/nbm.1549.","journal-title":"NMR Biomed"},{"issue":"6","key":"2210_CR36","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.amjmed.2009.11.012","volume":"123","author":"A Selva-O\u2019Callaghan","year":"2010","unstructured":"Selva-O\u2019Callaghan A, Grau JM, G\u00e1mez-Cenzano C, Vidaller-Palac\u00edn A, Mart\u00ednez-G\u00f3mez X, Trallero-Aragu\u00e1s E, et al. Conventional cancer screening versus PET\/CT in dermatomyositis\/polymyositis. Am J Med. 2010;123(6):558\u201362. https:\/\/doi.org\/10.1016\/j.amjmed.2009.11.012.","journal-title":"Am J Med"},{"issue":"2","key":"2210_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5114\/reum.2015.51510","volume":"53","author":"M Jakubaszek","year":"2015","unstructured":"Jakubaszek M, Kwiatkowska B, Ma\u015bli\u0144ska M. Polymyositis and dermatomyositis as a risk of developing cancer. Reumatologia. 2015;53(2):101\u20135. https:\/\/doi.org\/10.5114\/reum.2015.51510.","journal-title":"Reumatologia"},{"key":"2210_CR38","doi-asserted-by":"publisher","first-page":"883727","DOI":"10.3389\/fmed.2022.883727","volume":"9","author":"H Yildiz","year":"2022","unstructured":"Yildiz H, D\u2019abadie P, Gheysens O. The role of quantitative and semi-quantitative [18F] FDG-PET\/CT indices for evaluating disease activity and management of patients with dermatomyositis and polymyositis. Front Med (Lausanne). 2022;9:883727. https:\/\/doi.org\/10.3389\/fmed.2022.883727.","journal-title":"Front Med (Lausanne)"},{"key":"2210_CR39","doi-asserted-by":"publisher","unstructured":"Milisenda JC, Selva-O\u2019Callaghan A, Grau JM. The diagnosis and classification of polymyositis. J Autoimmun. 2014;48\u201349:118\u2009\u2212\u200921.\u00a0https:\/\/doi.org\/10.1016\/j.jaut.2014.01.025.","DOI":"10.1016\/j.jaut.2014.01.025"},{"issue":"2","key":"2210_CR40","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/rheumatology\/ken441","volume":"48","author":"MO Harris-Love","year":"2009","unstructured":"Harris-Love MO, Shrader JA, Koziol D, Pahlajani N, Jain M, Smith M, et al. Distribution and severity of weakness among patients with polymyositis, dermatomyositis, and juvenile dermatomyositis. Rheumatology (Oxford). 2009;48(2):134\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/ken441.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"2210_CR41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-006763","volume":"5","author":"M Tateyama","year":"2015","unstructured":"Tateyama M, Fujihara K, Misu T, Arai A, Kaneta T, Aoki M. Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation. BMJ Open. 2015;5(1): e006763. https:\/\/doi.org\/10.1136\/bmjopen-2014-006763.","journal-title":"BMJ Open"},{"issue":"1","key":"2210_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s41824-020-00084-w","volume":"4","author":"H Arai-Okuda","year":"2020","unstructured":"Arai-Okuda H, Norikane T, Yamamoto Y, Mitamura K, Fujimoto K, Takami Y, et al. 18F-FDG PET\/CT in patients with polymyositis\/dermatomyositis: correlation with serum muscle enzymes. Eur J Hybrid Imaging. 2020;4(1):14. https:\/\/doi.org\/10.1186\/s41824-020-00084-w.","journal-title":"Eur J Hybrid Imaging"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02210-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-025-02210-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-025-02210-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:16:26Z","timestamp":1781612186000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-025-02210-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2210"],"URL":"https:\/\/doi.org\/10.1186\/s12920-025-02210-8","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the 3rd Affiliated Hospital of Sun Yat-sen University and informed consents were obtained from both patients, and the parents of the 14-year-old.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consents for clinical details along with all identifying images to be published in this study were obtained from both patients and the parents of the 14-year-old patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}